Sheng Wang

Prof. Sheng Wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in World Neurosurgery
Verified
Journal Article
Closed access
XWXueyan Wan
Xueyan Wan
SLShengwen Liu
Shengwen Liu
SWSheng Wang
Sheng Wang
SZSuojun Zhang
Suojun Zhang
HYHongkuan Yang
Hongkuan Yang
Ting LeiTing Lei
Ting Lei

27 August 2015 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
SLShengwen Liu
Shengwen Liu
XWXueyan Wan
Xueyan Wan
SWSheng Wang
Sheng Wang
LHLulu Huang
Lulu Huang
MZMingxin Zhu
Mingxin Zhu
TLTing Lei
Ting Lei

9 December 2016 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
XWXueyan Wan
Xueyan Wan
TFTing Fan
Ting Fan
SWSheng Wang
Sheng Wang
SZSuojun Zhang
Suojun Zhang
SLShengwen Liu
Shengwen Liu
TLTing Lei
Ting Lei

5 January 2017 in Brain Injury
Verified
Journal Article
Closed access
SZSuojun Zhang
Suojun Zhang
SWSheng Wang
Sheng Wang
XWXueyan Wan
Xueyan Wan
SLShengwen Liu
Shengwen Liu
KSKai Shu
Kai Shu
TLTing Lei
Ting Lei
Background: Patients with traumatic epidural haematoma, undergoing the prompt and correct treatment, usually have favourable outcomes. However, secondary cerebral infarction may be life-threatening condition, as it is difficult to be identified before neurological impairment occurs. Objective: To evaluate the clinical data of patients with traumatic EDH and assess potential risk factors for post-operative cerebral infarction. Methods: The clinical data of patients with traumatic EDH were collected and analysed retrospectively. Results: The univariate analysis revealed 10 potential risk factors (the haematoma location, volume, the largest thickness and mid-line shift, basal cisterns compression, traumatic subarachnoid haemorrhage, pupil dilatation, pre-operative Glasgow Coma Scale score, ∆GCS and intraoperative brain pressure) for cerebral infarction with statistically significant difference. Of these factors, haematoma volume and basal cistern compression turned out to be the most significant risk factors through final multivariate logistic regression analysis. Conclusion: The findings of this study can provide predictive factors for development of cerebral infarction and information for clinical decision-making and future studies.

30 January 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SWSheng Wang
Sheng Wang
QJQian Jiang
Qian Jiang
YLYuan Liu
Yuan Liu
XZxincheng zhang
xincheng zhang
YHYimin Huang
Yimin Huang
HZHuaqiu Zhang
Huaqiu Zhang
Moyamoya disease (MMD) is a rare progressive cerebrovascular disorder characterized by the stenosis or occlusion of the terminal segments of the internal carotid arteries, leading to the development of abnormal collateral vascular networks. These networks are a compensatory mechanism for reduced blood flow to the brain. Despite extensive research, the exact etiology of MMD remains unknown, although recent studies suggest that immune system dysfunction plays a critical role in its pathogenesis. In particular, the involvement of immune cells such as T cells, macrophages, and dendritic cells has been increasingly recognized. These immune cells contribute to the inflammatory process and vascular remodeling observed in MMD patients, further complicating the disease’s progression. Inflammation and immune-mediated damage to the vessel walls may accelerate the narrowing and occlusion of arteries, exacerbating ischemic events in the brain. Additionally, studies have revealed that certain genetic and environmental factors can influence immune system activation in MMD, linking these pathways to disease development. This review aims to provide a comprehensive overview of the immune mechanisms at play in MMD, focusing on how immune cells participate in vascular injury and remodeling. Understanding these immunological processes may offer new therapeutic targets to halt or reverse disease progression, potentially leading to more effective treatment strategies for MMD.

22 August 2023 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
HFH.F. Fernandez
H.F. Fernandez
SPS.P. Pfister
S.P. Pfister
MLM. Leoni
M. Leoni
MBM. Berry
M. Berry
AGA. Gangadharan
A. Gangadharan
RSR. Sanchez
R. Sanchez